CCL2 and interstitial lung disease: On the other hand, serum levels of C-C motif ligand 2 (CCL2, a chemokine that is also referred to as monocyte chemoattractant protein-1) and IFNβ, were both reduced following the treatment of survivors with MDA5+ DM with ILD.